102 related articles for article (PubMed ID: 8693879)
41. Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer.
Nagai H; Negrini M; Carter SL; Gillum DR; Rosenberg AL; Schwartz GF; Croce CM
Cancer Res; 1995 Apr; 55(8):1752-7. PubMed ID: 7712484
[TBL] [Abstract][Full Text] [Related]
42. Fine needle aspiration of breast carcinoma: a preliminary cytoprognostic study.
Mouriquand J; Pasquier D
Acta Cytol; 1980; 24(2):153-9. PubMed ID: 6245554
[TBL] [Abstract][Full Text] [Related]
43. Immunocytochemical analysis of p63 and 34βE12 in fine needle aspiration cytology specimens for breast lesions: a potentially useful discriminatory marker between intraductal papilloma and ductal carcinoma in situ.
Hoshikawa S; Sano T; Hirato J; Oyama T; Fukuda T
Cytopathology; 2016 Apr; 27(2):108-14. PubMed ID: 25810244
[TBL] [Abstract][Full Text] [Related]
44. Pattern of chromosome 16q loss differs between an atypical proliferative lesion and an intraductal or invasive ductal carcinoma occurring subsequently in the same area of the breast.
Tsuda H; Takarabe T; Akashi-Tanaka S; Fukutomi T; Hirohashi S
Mod Pathol; 2001 May; 14(5):382-8. PubMed ID: 11353046
[TBL] [Abstract][Full Text] [Related]
45. Cytologic evaluation of prognostic markers in breast carcinoma.
Jayaram G; Elsayed EM
Acta Cytol; 2005; 49(6):605-10. PubMed ID: 16450899
[TBL] [Abstract][Full Text] [Related]
46. Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type.
Vos CB; ter Haar NT; Rosenberg C; Peterse JL; Cleton-Jansen AM; Cornelisse CJ; van de Vijver MJ
Br J Cancer; 1999 Dec; 81(8):1410-8. PubMed ID: 10604741
[TBL] [Abstract][Full Text] [Related]
47. Pseudoinvasion in intraductal carcinoma.
Tavassoli FA; Pestaner JP
Mod Pathol; 1995 May; 8(4):380-3. PubMed ID: 7567934
[TBL] [Abstract][Full Text] [Related]
48. Flow cytometric DNA analysis of excised breast lesions: use of fresh tissue needle aspirates obtained under guidance with mammography of the specimen.
Stomper PC; Stewart CC; Penetrante RB; Nava ME; Tsangaris TN
Radiology; 1992 Nov; 185(2):415-22. PubMed ID: 1329141
[TBL] [Abstract][Full Text] [Related]
49. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
50. Quantitative analysis of promoter hypermethylation in laser-microdissected archival specimens.
Lehmann U; Hasemeier B; Lilischkis R; Kreipe H
Lab Invest; 2001 Apr; 81(4):635-8. PubMed ID: 11304583
[No Abstract] [Full Text] [Related]
51. The gray zone in breast fine needle aspiration cytology. How to report on it?
Ozkara SK; Ustün MO; Paksoy N
Acta Cytol; 2002; 46(3):513-8. PubMed ID: 12040646
[TBL] [Abstract][Full Text] [Related]
52. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.
Shen CY; Yu JC; Lo YL; Kuo CH; Yue CT; Jou YS; Huang CS; Lung JC; Wu CW
Cancer Res; 2000 Jul; 60(14):3884-92. PubMed ID: 10919664
[TBL] [Abstract][Full Text] [Related]
53. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma.
el-Naggar AK; Hurr K; Batsakis JG; Luna MA; Goepfert H; Huff V
Cancer Res; 1995 Jun; 55(12):2656-9. PubMed ID: 7780981
[TBL] [Abstract][Full Text] [Related]
54. Diagnostic problems in tissues previously sampled by fine-needle aspiration.
Tabbara SO; Frierson HF; Fechner RE
Am J Clin Pathol; 1991 Jul; 96(1):76-80. PubMed ID: 1648878
[TBL] [Abstract][Full Text] [Related]
55. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
D'Adda T; Keller G; Bordi C; Höfler H
Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509
[TBL] [Abstract][Full Text] [Related]
56. Assessing invasion criteria in fine needle aspirates from breast carcinoma diagnosed as DICS or invasive carcinoma: can we identify an invasive component in addition to DCIS?
Sauer T; Garred O; Lømo J; Naess O
Acta Cytol; 2006; 50(3):263-70. PubMed ID: 16780019
[TBL] [Abstract][Full Text] [Related]
57. Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions.
Cleton-Jansen AM; Callen DF; Seshadri R; Goldup S; Mccallum B; Crawford J; Powell JA; Settasatian C; van Beerendonk H; Moerland EW; Smit VT; Harris WH; Millis R; Morgan NV; Barnes D; Mathew CG; Cornelisse CJ
Cancer Res; 2001 Feb; 61(3):1171-7. PubMed ID: 11221848
[TBL] [Abstract][Full Text] [Related]
58. Refinement of regional loss of heterozygosity for chromosome 11p15.5 in human breast tumors.
Winqvist R; Mannermaa A; Alavaikko M; Blanco G; Taskinen PJ; Kiviniemi H; Newsham I; Cavenee W
Cancer Res; 1993 Oct; 53(19):4486-8. PubMed ID: 8402619
[TBL] [Abstract][Full Text] [Related]
59. Cytologic findings with histologic correlation in 43 cases of mammary intraductal adenocarcinoma diagnosed by aspiration biopsy.
Cangiarella J; Waisman J; Simsir A
Acta Cytol; 2003; 47(6):965-72. PubMed ID: 14674064
[TBL] [Abstract][Full Text] [Related]
60. The significance of extracellular mucin in breast fine needle aspiration specimens.
Shield PW; Ribu DL; Cominos D
Cytopathology; 2016 Jun; 27(3):185-92. PubMed ID: 26104545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
